Benzinga
España
Italia
대한민국
日本
Français
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
Italia
대한민국
日本
Français
Login
Register
Benzinga
Premium Services
Financial News
Latest
Earnings
Guidance
Dividends
M&A
Buybacks
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Small-Cap
Markets
Pre-Market
After Hours
Movers
ETFs
Options
Cryptocurrency
Commodities
Bonds
Futures
Mining
Real Estate
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Investing Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
Analyst Ratings
Analyst Color
Latest Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Markets
Pre-Market
After Hours
Movers
ETFs
Options
Cryptocurrency
Commodities
Bonds
Futures
Mining
Real Estate
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Investing Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
Analyst Ratings
Analyst Color
Latest Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Recent
Markets
Mad Money Lightning Round
Jim Cramer: This Industrial Stock Is A Buy, Recommends Staying Away From Enterprise Software Companies
Cramer Calls MNTN 'Awful'—But Says To 'Pull The Trigger' On This 'Great Spec'
Jim Cramer: Crane Is A 'Good' Company, Recommends Holding This Tech Stock
Cramer Calls MNTN 'Awful'—But Says To 'Pull The Trigger' On This 'Great Spec'
Jim Cramer: Crane Is A 'Good' Company, Recommends Holding This Tech Stock
Cramer Says Skip CubeSmart, But Calls This 'Undervalued' Entertainment Giant A Buy
Jim Cramer Is Bullish On This Tech Stock: 'Continue To Own It'
Cramer Says Skip CubeSmart, But Calls This 'Undervalued' Entertainment Giant A Buy
Jim Cramer Is Bullish On This Tech Stock: 'Continue To Own It'
Jim Cramer Bears Down On EchoStar (SATS): 'I Think The Play Is Over'
Jim Cramer: Credo Technology Is A 'Winner,' Says No To This Tech Stock
Read More...
Mad Money Lightning Round Recent News
Jim Cramer Praises Elanco Animal Health: 'They've Turned That Company Around'
Cramer talks Elanco, Rocket Lab, Lithium Americas, Daktronics, M&T Bank and Ondas Holdings on the latest edition of Mad Money.
Jim Cramer On Lumen Technologies: Be Careful, It Has 'Run Too Much'
Cramer recommended caution with Lumen Technologies (LUMN) as it has run too much. Unusual Machines (UMAC) is losing money, while TopBuild (BLD) has had a significant run. Cramer doesn't trust Horizon Technology (HRZN) and is not interested in Cal-Maine Foods (CALM).
Jim Cramer: Sell This Major Energy Stock, Go With This Canadian Mining Company
Cramer said, although he likes Cencora, Cardinal Health Inc. has "got them all beat." Plus: Perpetua Resources is a "hot," but...
Cramer Says T-Mobile Is Being 'Hurt By The Death Star That's Elon Musk'
Jim Cramer recommends Enterprise Products Partners, maintains Lumentum and DuPont, but worries about T-Mobile due to Elon Musk's influence.
Jim Cramer Rejects MicroStrategy: 'I Just Want Bitcoin'
On CNBC's “Mad Money Lightning Round,” on Thursday, Jim Cramer said The Bank of Nova Scotia (NYSE:
Jim Cramer: SoundHound AI Doesn't Make Money, But This Consumer Cyclical Stock Is Going Higher
DA Davidson analyst Gil Luria, on Nov. 18, maintained SoundHound with a Buy and maintained a $17 price target.
Jim Cramer Says Avoid This Stock: 'The Only Thing Worse Than Housing Is...'
Cramer advised avoiding Dorman Products on Mad Money, citing weak housing and auto markets. He also discussed CoreWeave's strong performance and Alaska Air as a trading vehicle.
Jim Cramer: This Health Care Stock Has Been 'Horrendous'
Jim Cramer doesn't recommend Recursion Pharmaceuticals (NASDAQ: RXRX) due to weak earnings and CEO transition. Stock has mixed technicals and death cross.
Jim Cramer Names One Of His 'Absolute Favorite' Stocks
Jim Cramer recommends avoiding DigitalBridge Group, while Lumentum and MSCI are potential buys.
Jim Cramer: This Communication Services Stock Is A Buy, Recommends Holding On To Howmet Aerospace
Cramer chose not to recommend Marvell Technology, Inc. but advised holding on to Howmet Aerospace Inc. and Chubb.
Jim Cramer: This Tech Stock Is 'Losing Too Much Money,' Recommends Buying Mettler-Toledo
"Mad Money" host Jim Cramer recommends buying Mettler-Toledo International Inc. "You've got a good one there," he said.
'No One's Buying Homes Here': Cramer Warns On This Housing Stock
Cramer prefers Netflix (NFLX) over FuboTV (FUBO). Rocket Companies (RKT) and Regeneron Pharmaceuticals (REGN) also discussed. FDA approves new drug for Regeneron.
Jim Cramer: This Communication Services Stock Is 'Too Speculative'
Jim Cramer said this company is losing money and is "too speculative" for him. The "Mad Money" host recommends this instead.
Jim Cramer Warns 'The Business Is Really Bad' At This Consumer Cyclical Stock
Jim Cramer says he would not own CarMax(NYSE: KMX) stock due to bad business; supports holding ServiceNow(NYSE: NOW) & avoiding Conagra(NYSE: CAG).
Jim Cramer: Don't Buy This Health Care Stock Yet, It Is 'Still Too Expensive'
On CNBC's "Mad Money Lightning Round," Jim Cramer recommended waiting and not buying Doximity, adding that it is "still too expensive."
Jim Cramer: Joby Is 'Losing Too Much Money'
Jim Cramer finds Aquestive Therapeutics very interesting, while Amphenol Corporation is a great stock. Joby Aviation is losing money.
Jim Cramer Is Backing Off Bristol-Myers, But These 2 Chinese Stocks Are Good
"Mad Money" host Jim Cramer discusses Bristol-Myers Squibb, Baidu, Alibaba, Brinker and New Era Energy & Digital.
Jim Cramer: Own This Consumer Cyclical Stock And Don't Sell It
Cramer recommends owning TJX and not selling it. "TJX is really, really strong. It's what works in a bad market," he added.
Jim Cramer: Chipotle Is 'Too Expensive,' Buy This Plane Maker
On "Mad Money," Cramer discusses Henry Schein, Bloom Energy, Tyler Technologies, Boeing and Chipotle Mexican Grill.
Jim Cramer Says 'Take A Pass' On This Tech Stock, Won't Go Near Oils
Zoom Communications is a good company, Cramer says. Still, he advises, "take a pass." Plus: Viking Therapeutics, Profrac and Altria.
Jim Cramer Likes SAIC: 'It's An Inexpensive Stock'
On CNBC's "Mad Money Lightning Round," Jim Cramer said he likes Science Applications and recommended buying the stock.
Jim Cramer Says Stay Away From AT&T, Calls Nextracker 'Tremendous'
AT&T reported third-quarter operating revenues of $30.71 billion. It fell short of the analyst consensus estimate of $30.87 billion.
Jim Cramer Tells Investors To Avoid USA Rare Earth — For Now
Cramer recommends staying away from USAR, but buying OLLI. Centrus Energy to release Q3 earnings, expected to report positive earnings and revenue.
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started